Honored to be part of Siloam Oncology Summit 2026, held on 22nd–24th May 2026 at Shangri-La Hotel Jakarta — bringing together healthcare professionals, researchers, and innovators to advance oncology and precision medicine in Indonesia. ✨

At NalaGenetics, together with Strand Life Sciences, we showcased oncology-focused genomic solutions supporting every stage of cancer care — from prevention and early detection to personalized treatment.

As part of our ongoing collaboration with the Siloam network, we continue supporting precision oncology initiatives through solutions including RxOnco™, RxReact Tamoxifen™, MammoReady™, Whole Exome Sequencing, and ExomePlus.

Our showcased solutions included:

🧬 HCT Plus — 137 Gene Hereditary Cancer Panel

🧬 CancerSpot for early cancer detection

🧬 Nexus & Nexus Plus — 500 Gene Panel

🧬 Targeted Gene Panels for Lung, Colon, Breast, Thyroid, and Endometrial cancers

🧬 RxMax™ — pharmacogenomic insights across 240+ medications

🧬 RxOnco™ — pharmacogenomic testing for optimized chemotherapy management

We were also delighted to be supported by Health+Care Drink from Erlimpex, featuring herbal wellness beverages made with natural ingredients such as Mengkudu, Temulawak, and Echinacea 🌿

Special thanks to Ramesh Srinivasan, Director of International Markets at Strand Life Sciences, for joining us and contributing to valuable discussions on precision medicine and genomic innovation.

Thank you to everyone who visited our booth and shared meaningful discussions throughout the event.

#NalaGenetics #PrecisionMedicine #PrecisionOncology #Genomics #CancerCare #HealthcareInnovation #SiloamOncologySummit2026 #StrandLifeSciences